Sort
51,570 grants matching “autoimmune disease”
Protecting Pancreatic Islet Grafts from Rejection
$999,406Uwe D. Staerz · Isogenis, Inc. · R44 · FY2006 · DK
i-AKC: Integrated AIRR Knowledge Commons
$999,330Lindsay G. Cowell · Ut Southwestern Medical Center · U24 · FY2023 · AI
A Point of Care Urine Test to Aid Diagnosis of Aspergillosis
$999,316Kieren A. Marr · Pearl Diagnostics, Inc. · SB1 · FY2025 · AI
Rapid Multiplexed Detection of Cancer Related Proteins
$999,237Martin Gleeson · Genalyte, Inc. · N44 · FY2013 · CA
7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors
$999,200Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2024 · CA
7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors
$999,200Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2023 · CA
Protein Modifications Involved in Cell Signaling
$999,153Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Proteome Capture in Hydrogel Beads for High Resolution Single Cell Analysis
$999,016Peter Krutzik · Cytorum, Inc. · R44 · FY2023 · AI
Protecting Pancreatic Islet Grafts from Rejection
$998,749Uwe D. Staerz · Isogenis, Inc. · R44 · FY2007 · DK
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening
$998,661Steven Joseph Darnell · Dnastar, Inc. · R44 · FY2021 · AI
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening
$998,661Steven Joseph Darnell · Dnastar, Inc. · R44 · FY2022 · AI
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$998,658Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2021 · DE
A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease
$998,618Jack A. Syage · Immunogenics, Llc · U44 · FY2021 · AI
Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation
$998,606William R Clarke · Xlock Biosciences, Llc · R44 · FY2023 · AR
Multidimensional investigation of auditory dysfunction in Down syndrome
$998,372Joaquin M. Espinosa · University Of Colorado Denver · R01 · FY2025 · DC
A 3D vascularized islet biomimetic to model type 1 diabetes
$998,312Maike Sander · University Of California, San Diego · UH3 · FY2023 · DK
A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease
$998,228Jack A. Syage · Immunogenics, Llc · U44 · FY2020 · AI
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects
$998,210Jeffrey S King · Virogenomics Biodevelopment, Inc. · R44 · FY2020 · AI
Selective Depletion of Insulin-Specific B cells to Prevent Type 1 Diabetes
$998,123Todd C Zion · Akston Biosciences Corporation · R44 · FY2017 · DK
Protecting Pancreatic Islet Grafts from Rejection
$998,068Uwe D. Staerz · Isogenis, Inc. · R44 · FY2008 · DK
Safe and effective anti CD154 antibodies for therapeutic intervention
$998,002Michael Rosenzweig · Immunext, Inc. · R44 · FY2013 · AI
The Environmental Triggers of Diabetes (TEDDY) in Sweden
$997,608Ake Lernmark · Lunds Universitet · U01 · FY2008 · DK
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$997,404Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2020 · AI
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses
$997,348James E Crowe · University Of Texas Med Br Galveston · U19 · FY2018 · AI
Project 1: MiCAPP - Mechanisms of the CentrAlized Pain Phenotype
$997,215Daniel J Clauw · University Of Michigan At Ann Arbor · P50 · FY2017 · AR